![PET/CT evaluation of response to chemotherapy in non-small cell lung cancer: PET response criteria in solid tumors (PERCIST) versus response evaluation criteria in solid tumors (RECIST) - Ding - Journal of Thoracic PET/CT evaluation of response to chemotherapy in non-small cell lung cancer: PET response criteria in solid tumors (PERCIST) versus response evaluation criteria in solid tumors (RECIST) - Ding - Journal of Thoracic](https://cdn.amegroups.cn/journals/pbpc/files/journals/2/articles/2518/public/2518-PB8-R1.png/w300)
PET/CT evaluation of response to chemotherapy in non-small cell lung cancer: PET response criteria in solid tumors (PERCIST) versus response evaluation criteria in solid tumors (RECIST) - Ding - Journal of Thoracic
![Validity of RECIST Version 1.1 for Response Assessment in Metastatic Cancer: A Prospective, Multireader Study | Radiology Validity of RECIST Version 1.1 for Response Assessment in Metastatic Cancer: A Prospective, Multireader Study | Radiology](https://pubs.rsna.org/cms/10.1148/radiol.2018180648/asset/images/medium/radiol.2018180648.tbl2.gif)
Validity of RECIST Version 1.1 for Response Assessment in Metastatic Cancer: A Prospective, Multireader Study | Radiology
![Comparison of RECIST version 1.0 and 1.1 in assessment of tumor response by computed tomography in advanced gastric cancer - Chinese Journal of Cancer Research Comparison of RECIST version 1.0 and 1.1 in assessment of tumor response by computed tomography in advanced gastric cancer - Chinese Journal of Cancer Research](http://www.cjcrcn.org/data/pic/3073_0.png)
Comparison of RECIST version 1.0 and 1.1 in assessment of tumor response by computed tomography in advanced gastric cancer - Chinese Journal of Cancer Research
![Table 1 from New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). | Semantic Scholar Table 1 from New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/871ed6d95d395e93dce6e1cb05a39f498296c910/8-Table1-1.png)
Table 1 from New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). | Semantic Scholar
![Pharmaceutics | Free Full-Text | Comparison of Choi, RECIST and Somatostatin Receptor PET/CT Based Criteria for the Evaluation of Response and Response Prediction to PRRT Pharmaceutics | Free Full-Text | Comparison of Choi, RECIST and Somatostatin Receptor PET/CT Based Criteria for the Evaluation of Response and Response Prediction to PRRT](https://www.mdpi.com/pharmaceutics/pharmaceutics-14-01278/article_deploy/html/images/pharmaceutics-14-01278-g001.png)
Pharmaceutics | Free Full-Text | Comparison of Choi, RECIST and Somatostatin Receptor PET/CT Based Criteria for the Evaluation of Response and Response Prediction to PRRT
Utilization of target lesion heterogeneity for treatment efficacy assessment in late stage lung cancer | PLOS ONE
![Frontiers | Response Evaluation and Survival Prediction Following PD‐1 Inhibitor in Patients With Advanced Hepatocellular Carcinoma: Comparison of the RECIST 1.1, iRECIST, and mRECIST Criteria Frontiers | Response Evaluation and Survival Prediction Following PD‐1 Inhibitor in Patients With Advanced Hepatocellular Carcinoma: Comparison of the RECIST 1.1, iRECIST, and mRECIST Criteria](https://www.frontiersin.org/files/Articles/764189/fonc-11-764189-HTML-r1/image_m/fonc-11-764189-t002.jpg)